Biotechnology

Bradmer Completes Previously Announced Private Placement

WuXi PharmaTech Inc. announced today that its previously announced transaction with Charles River Laboratories International Inc. has been terminated by mutual agreement due to Charles River shareholder opposition. Under the terms of the ...

Charles River Laboratories International, Inc. , a leading global provider of research models and associated services and of preclinical drug development services, today announced that it has mutually agreed with WuXi PharmaTech Inc. to terminate ...

Medistem Inc. announced today publication of a peer reviewed paper identifying a molecule found on the company's lead product, the universal donor Endometrial Regenerative Cell , as a key component of cellular escape from immune attack. The study, ...

Wright Medical Group, Inc. , a global orthopaedic medical device company, is pleased to announce the launch of the EVOLUTION Medial- Pivot Knee System. The EVOLUTION Knee System represents Wright's next generation in medial-pivot knees, featuring ...

Robbins Geller Rudman & Dowd LLP today announced that a class action has been commenced on behalf of an institutional investor in the United States District Court for the Eastern District of Missouri on behalf of purchasers of the common stock ...

Actient Pharmaceuticals, LLC , a portfolio company of GTCR, announced today the company successfully completed a transaction to license and acquire six pharmaceutical products from UCB, Inc., a subsidiary of UCB SA , an international ...

Inhibitex, Inc. announced today that it will host a conference call on Tuesday, August 10, 2010 at 9:00 a.m. EDT to review the Company's second quarter financial results and provide an update on recent corporate developments. The Company will issue ...